Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 236.60
Bid: 235.60
Ask: 236.00
Change: 1.60 (0.68%)
Spread: 0.40 (0.17%)
Open: 234.20
High: 237.20
Low: 233.20
Prev. Close: 235.00
CRST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

19 Mar 2020 07:00

RNS Number : 7187G
Crest Nicholson Holdings PLC
19 March 2020
 

The information contained in this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

 

Crest Nicholson Holdings plc

(the "Company" or "Crest Nicholson")

 

COVID-19 Update

 

Crest Nicholson today issues an update on the impact of COVID-19 on the business and in advance of its Annual General Meeting ("AGM") which will be held at 10.30 a.m. on Tuesday 24 March 2020 at Brooklands Hotel, Brooklands Drive, Weybridge, Surrey KT13 0SL.

Since the start of the calendar year, up to and including 16 March 2020, we have traded in-line with our expectations and have seen continued improvements in website traffic, footfall and reservations. We have also made strong progress in implementing the changes to our business model and operations that we outlined in our updated strategy at the end of January 2020.

However, the Board has carefully considered this week's rapidly evolving Government guidance in respect of COVID-19 and expects this to have a significant impact on visitor levels, production capability and trading performance over an unclear timeline. Accordingly, the Company has taken the difficult decision to cancel its final dividend of 21.8 pence per share, otherwise payable on 9 April 2020. Resolution 2 will therefore be withdrawn from next week's AGM.

In addition, the Company also announces that it is suspending all existing financial guidance until both the severity and duration of the COVID-19 impact becomes clearer.

The Board recognises that these are significant steps to take, but when faced with this unprecedented and unpredictable situation, considers it to be prudent to protect the Company's cash position and maintain a robust balance sheet. The Executive Leadership Team has also moved quickly in identifying further measures that will increase cash generation, and reduce cash outflow, enabling the business to trade through this period of prolonged uncertainty.

The Company has made arrangements to fully draw its £250m revolving credit facility, resulting in available cash of £185m. In the ordinary course of business, the Company has a strong balance sheet and has made good progress in reducing levels of capital employed in the current financial year. The Board has only considered it necessary to take such decisive action because of the anticipated impact from COVID-19.

We consider these measures to be in the best interests of all our stakeholders and will best ensure the long-term viability of the business at this time. Our number one priority will always be the health and welfare of our employees and sub-contractors and we are also taking the necessary steps to maintain that commitment.

 

For further information, please contact:

 

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

 

Finsbury +44 (0) 20 7251 3801

Faeth Birch

Philip Walters

 

The person responsible for arranging the release of this announcement on behalf of the Company is Kevin Maguire, General Counsel & Company Secretary.

 

19 March 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRXVLLFBXLFBBE
Date   Source Headline
14th May 20217:00 amRNSDisposal
10th May 20211:00 pmRNSHolding(s) in Company
4th May 20211:03 pmRNSDirectorate Change
19th Apr 20212:31 pmRNSBlock listing Interim Review
23rd Mar 20214:26 pmRNSResult of AGM
23rd Mar 20217:00 amRNSAGM Statement
15th Mar 20219:27 amRNSHolding(s) in Company
5th Mar 20211:56 pmRNSHolding(s) in Company
4th Mar 20214:17 pmRNSHolding(s) in Company
25th Feb 20215:14 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSAnnual Integrated Report and Notice of AGM
10th Feb 20211:52 pmRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSFinal Results
21st Jan 20215:14 pmRNSHolding(s) in Company
24th Nov 20203:18 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
19th Oct 20209:00 amRNSBlock listing Interim Review
23rd Sep 20204:49 pmRNSDirector/PDMR Shareholding
23rd Sep 202012:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:16 amRNSDirector/PDMR Shareholding
22nd Sep 20209:14 amRNSDirector/PDMR Shareholding
21st Sep 202012:48 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSDirector/PDMR Shareholding
7th Aug 20201:51 pmRNSHolding(s) in Company
5th Aug 202012:43 pmRNSHolding(s) in Company
5th Aug 202011:19 amRNSDirector/PDMR Shareholding
24th Jul 20208:00 amRNSDirector/PDMR Shareholding
6th Jul 20202:54 pmRNSDirector/PDMR Shareholding
3rd Jul 20201:03 pmRNSDirector/PDMR Shareholding
3rd Jul 202010:36 amRNSDirector/PDMR Shareholding
29th Jun 202010:31 amRNSDirector Declaration
26th Jun 202011:48 amRNSDirector/PDMR Shareholding
26th Jun 202011:34 amRNSDirector/PDMR Shareholding
26th Jun 202011:34 amRNSDirector/PDMR Shareholding
26th Jun 202010:18 amRNSDirector/PDMR Shareholding
26th Jun 202010:15 amRNSDirector/PDMR Shareholding
24th Jun 20207:00 amRNSHalf-year Report
19th Jun 202011:49 amRNSHolding(s) in Company
18th Jun 20201:29 pmRNSCovid Corporate Finance Facility
5th Jun 20204:33 pmRNSHolding(s) in Company
3rd Jun 20203:29 pmRNSHolding(s) in Company
1st Jun 20203:12 pmRNSHolding(s) in Company
20th May 20207:00 amRNSHolding(s) in Company
13th May 20207:00 amRNSCOVID-19 Update
1st May 20201:38 pmRNSDirector Declaration
27th Apr 202010:52 amRNSDisclosure of Rights Attached to Equity Shares
17th Apr 202010:00 amRNSBlock listing Interim Review
9th Apr 20204:02 pmRNSCOVID-19 Update
2nd Apr 20205:10 pmRNSHolding(s) in Company
2nd Apr 20209:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.